AU4375499A - Mucosal targeting immunisation - Google Patents

Mucosal targeting immunisation

Info

Publication number
AU4375499A
AU4375499A AU43754/99A AU4375499A AU4375499A AU 4375499 A AU4375499 A AU 4375499A AU 43754/99 A AU43754/99 A AU 43754/99A AU 4375499 A AU4375499 A AU 4375499A AU 4375499 A AU4375499 A AU 4375499A
Authority
AU
Australia
Prior art keywords
immunisation
mucosal targeting
mucosal
targeting
targeting immunisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43754/99A
Other versions
AU751970B2 (en
Inventor
Therese Jourdier
Bernard Meignier
Catherine Moste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Publication of AU4375499A publication Critical patent/AU4375499A/en
Application granted granted Critical
Publication of AU751970B2 publication Critical patent/AU751970B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU43754/99A 1998-06-26 1999-06-25 Mucosal targeting immunisation Ceased AU751970B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808353 1998-06-26
FR98/08353 1998-06-26
PCT/FR1999/001539 WO2000000217A1 (en) 1998-06-26 1999-06-25 Mucosal targeting immunisation

Publications (2)

Publication Number Publication Date
AU4375499A true AU4375499A (en) 2000-01-17
AU751970B2 AU751970B2 (en) 2002-09-05

Family

ID=9528094

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43754/99A Ceased AU751970B2 (en) 1998-06-26 1999-06-25 Mucosal targeting immunisation

Country Status (4)

Country Link
EP (1) EP1089758A1 (en)
AU (1) AU751970B2 (en)
CA (1) CA2335506A1 (en)
WO (1) WO2000000217A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931398A (en) * 1973-06-20 1976-01-06 Colgate-Palmolive Company Method for local immunization against dental caries
NO153458C (en) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar PROCEDURE FOR THE PREPARATION OF PROPHYLAXY VACCINE AND TREATMENT OF RING WORM OF FUR ANIMALS AND Rabbits CAUSED BY TRICHOPHYTON MENTAGROPHYTES.
US5462734A (en) * 1990-11-02 1995-10-31 Wisconsin Alumni Research Foundation Bovine herpesvirus vaccine and method of using same
FR2751879B1 (en) * 1996-07-30 1998-10-30 Transgene Sa PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND PAPILLOMAVIRUS INFECTIONS

Also Published As

Publication number Publication date
WO2000000217A1 (en) 2000-01-06
AU751970B2 (en) 2002-09-05
CA2335506A1 (en) 2000-01-06
EP1089758A1 (en) 2001-04-11

Similar Documents

Publication Publication Date Title
AU9623898A (en) Vaccines
AU4525799A (en) Requirements matching
AU4070097A (en) Mucosal immunogens for novel vaccines
AU2001290707A1 (en) System for transmitting syndicated programs over the internet
AU5508899A (en) Nozzle
AU5779499A (en) Organelle targeting sequences
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AUPP210698A0 (en) Fin
AU8506798A (en) Water targeting game
AU4376199A (en) Mucosal targeting immunisation
AU3740499A (en) Agricultural adjuvant
AU1866100A (en) Luminous sweet
AU2609599A (en) Sensor-coupling
AU4375499A (en) Mucosal targeting immunisation
AU2724799A (en) Novel endo-xylogalacturonase
AU2754599A (en) Mucosal microparticle conjugate vaccine
AU5778299A (en) Sialidases as mucosal adjuvants
AU5429699A (en) Drug targeting
AU1386400A (en) Extract
AU6075498A (en) Vaccines
AU1055399A (en) Rollerboard
AU4787497A (en) Improved striking means
AU9690798A (en) Goggle
AU2840799A (en) 1-phosphanorbornadienes
AUPP700598A0 (en) Transcutaneous immunisation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)